Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
4/1/2022 | $1.50 | Underperform | Credit Suisse |
3/3/2022 | $10.00 → $2.00 | Outperform → Sector Perform | RBC Capital |
3/2/2022 | Buy → Hold | Truist | |
3/2/2022 | $2.00 | Buy → Hold | Truist Securities |
1/7/2022 | $6.00 → $3.00 | Neutral → Underperform | Credit Suisse |
1/5/2022 | $7.50 → $3.50 | Buy → Underperform | B of A Securities |
11/15/2021 | $7.00 → $6.00 | Neutral | Credit Suisse |
11/11/2021 | $13.00 → $5.50 | Equal-Weight | Morgan Stanley |
3 - GoHealth, Inc. (0001808220) (Issuer)
4 - GoHealth, Inc. (0001808220) (Issuer)
4 - GoHealth, Inc. (0001808220) (Issuer)
CHICAGO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced that the company will release its third quarter 2024 financial results on the morning of November 7, 2024. Chief Executive Officer, Vijay Kotte, and Chief Financial Officer, Brendan Shanahan, will host a conference call and live audio webcast on the day of the release at 8:00 a.m. (ET) to discuss the results. A live audio webcast of the conference call will be available via GoHealth's Investor Relations website, https://investors.gohealth.com/. A replay of the call will be available via webcast for on-demand
CHICAGO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- GoHealth Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company") today announced Vijay Kotte, CEO of GoHealth, will present at the LD Micro Main Event Investor Conference on Tuesday, October 29th, 2024, at The Luxe Sunset Boulevard, Los Angeles, CA. The Company's presentation is scheduled to begin at 3:00 pm CT. The presentation will be webcast. Register to watch the virtual presentation here GOCO Investor Presentation at LD Micro Main Event. About GoHealth, Inc.GoHealth is a leading health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decision
CHICAGO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- As the Medicare Annual Enrollment Period (AEP) begins, GoHealth, Inc. (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, today announced the launch of AI and proprietary technology tools dedicated to increasing efficiency and improving consumer experience. This new technology is designed to ensure ‘peace of mind' for consumers with their healthcare decisions, amidst new data from GoHealth suggesting that millions of Medicare Advantage beneficiaries are expected to experience an unprecedented period of disruption this AEP. In an analysis of more than 5,000 Medicare Advantage plans from top health i
8-K - GoHealth, Inc. (0001808220) (Filer)
8-K - GoHealth, Inc. (0001808220) (Filer)
8-K - GoHealth, Inc. (0001808220) (Filer)
SC 13D/A - GoHealth, Inc. (0001808220) (Subject)
SC 13D/A - GoHealth, Inc. (0001808220) (Subject)
SC 13D/A - GoHealth, Inc. (0001808220) (Subject)
Credit Suisse resumed coverage of GoHealth with a rating of Underperform and set a new price target of $1.50
RBC Capital downgraded GoHealth from Outperform to Sector Perform and set a new price target of $2.00 from $10.00 previously
Truist downgraded GoHealth from Buy to Hold
4 - GoHealth, Inc. (0001808220) (Issuer)
CHICAGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, today announced the appointment of Brendan Shanahan as Chief Financial Officer (CFO), effective October 14, following a comprehensive search process. Mr. Shanahan, a seasoned executive with over 30 years of financial leadership experience and over 20 years of expertise in the Medicare Advantage space, will oversee GoHealth's financial strategy and operations, contributing to the company's profitable growth and innovation efforts. "Brendan's extensive expertise in financial strategy, M&A, operational leadership, and deep knowledge of t
CHICAGO, Dec. 6, 2021 /PRNewswire/ -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced today that Vance Johnston will join the Company as Chief Financial Officer (CFO) on December 7, 2021. As previously announced, Travis Matthiesen, the Company's current CFO, will transition to the role of Chief Transformation Officer and will work closely with Johnston to ensure a smooth transition. "We are very pleased that Vance will be joining the GoHealth executive team as CFO," said Clint Jones, co-fou
CHICAGO, Dec. 1, 2020 /PRNewswire/ -- GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace, announced today that Dr. Paul Hain, M.D. has joined the company as Chief Medical Officer. In this newly created role, Dr. Hain will work side-by-side with GoHealth's growing TeleCare team, directly building clinical functions within the recently developed Encompass Platform, a digital health solution that provides strategic value to GoHealth members and enterprise partners. Dr. Hain will focus on key member touchpoints including care management and navigation, provider and value-based care engagement, pharmacy engagement, health risk assessments, social determinant of he
CHICAGO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced that the company will release its third quarter 2024 financial results on the morning of November 7, 2024. Chief Executive Officer, Vijay Kotte, and Chief Financial Officer, Brendan Shanahan, will host a conference call and live audio webcast on the day of the release at 8:00 a.m. (ET) to discuss the results. A live audio webcast of the conference call will be available via GoHealth's Investor Relations website, https://investors.gohealth.com/. A replay of the call will be available via webcast for on-demand
CHICAGO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and six months ended June 30, 2024. Second Quarter Highlights Second quarter 2024 net revenues of $105.9 million, a $36.9 million decrease compared to $142.8 million in the prior year period.Second quarter 2024 Submissions of 152,394, a 6% decrease compared to 162,837 Submissions in the prior year period, driven by an increase in Submissions generated by GoHealth's internal captive agents offset by a decrease in Submissions generated by our external GoPartn
CHICAGO, July 25, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced that the company will release its second quarter 2024 financial results on the morning of August 8, 2024. Chief Executive Officer, Vijay Kotte, and interim Chief Financial Officer, Katie O'Halloran, will host a conference call and live audio webcast on the day of the release at 8:00 a.m. (ET) to discuss the results. A live audio webcast of the conference call will be available via GoHealth's Investor Relations website, https://investors.gohealth.com/. A replay of the call will be available via webcast for
https://www.statnews.com/2024/06/21/medicare-coverage-wegovy-weight-loss-cancer-blood-tests-grail/
O'Halloran, current Chief Accounting Officer, brings 30 years of experience in Finance and Accounting at public and private companies Former CFO Jason Schulz departs for personal reasons after building high-performing finance organization during company turnaround Company to conduct search process for permanent CFOCHICAGO, June 04, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced that its Board of Directors has appointed Katherine O'Halloran, Chief Accounting Officer, as interim Chief Financial Officer.
GoHealth (NASDAQ:GOCO) reported quarterly losses of $(0.85) per share which beat the analyst consensus estimate of $(0.95) by 10.53 percent. The company reported quarterly sales of $185.600 million which beat the analyst consensus estimate of $180.154 million by 3.02 percent. This is a 1.33 percent increase over sales of $183.158 million the same period last year.